当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析

君实生物-U

(688180)

  

流通市值:252.99亿  总市值:326.16亿
流通股本:7.65亿   总股本:9.86亿

君实生物-U(688180)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-2.60亿元,每股收益-0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益566916.01万元,未分配利润-1057586.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1089706.98万元,负债522790.97万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入500,591,459.941,948,317,315.721,271,200,009.95786,056,275.43
营业总成本782,539,195.353,215,859,236.062,261,152,311.321,434,750,281.6
营业利润-281,715,865.28-1,338,824,837.02-969,121,005.27-675,685,390.06
利润总额-286,837,114.51-1,357,557,181.39-984,644,050.09-684,157,875.98
净利润-259,586,438.78-1,380,108,858.26-988,725,690.94-687,709,041.49
其他综合收益-10,204,644.58-17,870,045.74-47,944,698.9-24,342,498.84
综合收益总额-269,791,083.36-1,397,978,904-1,036,670,389.84-712,051,540.33
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计4,255,015,311.224,283,817,107.054,585,525,675.864,820,896,908.34
非流动资产合计6,642,054,455.586,498,143,303.056,272,087,848.846,168,116,553.27
资产总计10,897,069,766.810,781,960,410.110,857,613,524.710,989,013,461.61
流动负债合计3,044,658,054.062,493,923,829.632,296,970,306.442,286,205,148.62
非流动负债合计2,183,251,649.142,355,906,816.322,280,702,743.872,098,250,555.34
负债合计5,227,909,703.24,849,830,645.954,577,673,050.314,384,455,703.96
归属于母公司股东权益合计5,620,244,628.635,860,424,336.296,172,509,756.396,477,925,830.39
股东权益合计5,669,160,063.65,932,129,764.156,279,940,474.396,604,557,757.65
负债和股东权益合计10,897,069,766.810,781,960,410.110,857,613,524.710,989,013,461.61
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计803,419,825.511,916,527,984.341,396,882,602.67867,131,013.12
经营活动现金流出小计827,751,022.013,350,369,193.882,510,354,687.281,732,482,684.72
经营活动产生的现金流量净额-24,331,196.5-1,433,841,209.54-1,113,472,084.61-865,351,671.6
投资活动现金流入小计490,394,088.861,957,267,588.79941,248,272277,237,849.24
投资活动现金流出小计832,019,803.482,850,049,722.352,024,759,021.671,225,713,348.07
投资活动产生的现金流量净额-341,625,714.62-892,782,133.56-1,083,510,749.67-948,475,498.83
筹资活动现金流入小计1,422,331,063.182,314,600,434.751,933,431,848.111,438,269,008.85
筹资活动现金流出小计1,035,553,067.931,291,454,659.771,033,401,651.88695,885,457.77
筹资活动产生的现金流量净额386,777,995.251,023,145,774.98900,030,196.23742,383,551.08
汇率变动对现金及现金等价物的影响-791,648.4312,014,641.06-6,855,136.194,770,876.49
现金及现金等价物净增加额20,029,435.7-1,291,462,927.06-1,303,807,774.24-1,066,672,742.86
期末现金及现金等价物余额2,506,708,544.522,486,679,108.822,474,334,261.642,711,469,293.02
最新报告期:2025-05-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
方正证券许睿,周超泽-0.690.030.312025-05-05
太平洋周豫,霍亮,戎晓婕-0.68-0.030.572025-04-30
太平洋周豫,霍亮,戎晓婕-0.68-0.030.572025-03-31
TOP↑